NEO · trading date Oct 12, 2026 · previous close $16.36 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
—
Net income
-$108.03M
Total assets
$1.36B
Total liabilities
$523.27M
Stockholders' equity
$836.56M
Cash & equivalents
$159.62M
Operating income
-$115.88M
Operating cash flow
$5.23M
Capital expenditures
$27.01M
Fiscal year 2025, via 10-K filed 2026-02-17.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$21.78M
Free cash flow margin
—
Liabilities / assets
38.5%
Equity / assets
61.5%
CapEx / revenue
—
Operating cash flow / net income
-0.05×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Fort Myers, FL 33912
9490 NEOGENOMICS WAY
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:25 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.